Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,361 active trials259 approved drugs3,860 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,753 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00186823 | Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies | completed | Phase 3 | 57 | St. Jude Children's Research HospitalOTHER | 1 | Jan 29, 2009 | clinicaltrials |
| NCT00263783 | Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors | completed | Phase 1 | 24 | MedImmune LLCINDUSTRY | 1 | Jan 29, 2009 | clinicaltrials |
| NCT00115440 |
| BNCT to Treat Glioma That Has Progressed Following Radiotherapy |
| completed |
| Phase 1 / Phase 2 |
| 22 |
| Boneca CorporationINDUSTRY |
| 1 |
| Jan 28, 2009 |
| clinicaltrials |
| NCT00245492 | Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening. | completed | N/A | 792 | Indiana UniversityOTHER | 1 | Jan 28, 2009 | clinicaltrials |
| NCT00276211 | Diffusion Weighted MRI for Lymphnodes in the Axilla | completed | — | 10 | Copenhagen University Hospital at HerlevOTHER | 1 | Jan 28, 2009 | clinicaltrials |
| NCT00430651 | Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) | completed | Phase 3 | 135 | Hellenic Oncology Research GroupOTHER | 1 | Jan 28, 2009 | clinicaltrials |
| NCT00628732 | A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors | completed | Phase 2 | 36 | Children's Medical Center DallasOTHER | 1 | Jan 28, 2009 | clinicaltrials |
| NCT00207805 | The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma | completed | Phase 3 | 202 | Centre National de Greffe de Moelle OsseuseOTHER_GOV | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00252889 | Doxil Topotecan Doublet Cancer Study | completed | Phase 1 | 20 | Christiana Care Health ServicesOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00829335 | Anatomical Resection of the Liver for Hepatocellular Carcinoma: a New Ultrasound Guided Approach | completed | — | 30 | University of MilanOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00516152 | Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT | completed | Phase 2 | 36 | University of California, San FranciscoOTHER | 1 | Jan 26, 2009 | clinicaltrials |
| NCT00193544 | Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma | completed | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 0 | Jan 23, 2009 | clinicaltrials |
| NCT00193570 | Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors | completed | Phase 1 | 20 | SCRI Development Innovations, LLCOTHER | 0 | Jan 23, 2009 | clinicaltrials |
| NCT00315861 | Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies | completed | Phase 1 | 15 | SCRI Development Innovations, LLCOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00611793 | PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies | completed | Phase 1 | 50 | SCRI Development Innovations, LLCOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00007540 | Study of Prostate Cancer in Black and White U.S. Veterans | completed | — | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00018538 | Calcifidol Therapy in Men With Cancer | completed | Phase 2 | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00018551 | Chemoprevention With Folic Acid | completed | Phase 2 | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00108264 | Tumor RNA Transfected Dendritic Cell Vaccines | completed | Phase 1 | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00116610 | Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer | completed | Phase 2 | 75 | Poniard PharmaceuticalsINDUSTRY | 3 | Jan 21, 2009 | clinicaltrials |
| NCT00116896 | Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors | completed | Phase 1 | 25 | OSI PharmaceuticalsINDUSTRY | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00216801 | Relationship of Ochratoxin A to Upper Urologic Cancers | completed | — | 60 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00826033 | Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer | completed | — | — | Gunma UniversityOTHER | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00167648 | Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer(NE2) | completed | Phase 2 | 17 | University of WashingtonOTHER | 1 | Jan 19, 2009 | clinicaltrials |
| NCT00364624 | Adrenal Function in Patients With Newly Diagnosed Lung Cancer | completed | — | 133 | Princess Margaret Hospital, Hong KongOTHER_GOV | 1 | Jan 16, 2009 | clinicaltrials |
| NCT00581880 | Measuring Hope and Hopelessness in Cancer | completed | — | 288 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 15, 2009 | clinicaltrials |
| NCT00142532 | Acupuncture for Post-Thoracotomy Pain | completed | Phase 3 | 162 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 14, 2009 | clinicaltrials |
| NCT00496301 | Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC(SOGUG-02-06) | completed | Phase 2 | 40 | Spanish Oncology Genito-Urinary GroupOTHER | 1 | Jan 14, 2009 | clinicaltrials |
| NCT00533533 | A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer(DO for AGC) | completed | Phase 1 / Phase 2 | 68 | Samsung Medical CenterOTHER | 1 | Jan 14, 2009 | clinicaltrials |
| NCT00820417 | Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib | completed | Phase 1 | 63 | Harrison Clinical ResearchINDUSTRY | 2 | Jan 12, 2009 | clinicaltrials |
| NCT00049790 | Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer | completed | Phase 2 | — | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jan 9, 2009 | clinicaltrials |
| NCT00364195 | Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer | completed | Phase 2 | 33 | YM BioSciencesINDUSTRY | 1 | Jan 9, 2009 | clinicaltrials |
| NCT00222027 | Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial(GRAALL2003) | completed | Phase 2 | 300 | University Hospital, ToulouseOTHER | 1 | Jan 7, 2009 | clinicaltrials |
| NCT00579917 | Behavioral Intervention For BMT/SCT Survivors(BMT/SCT) | completed | — | 133 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 7, 2009 | clinicaltrials |
| NCT00809484 | Arimidex Bone Mass Index and Oral Bisphosphonates(ARBI) | completed | — | 220 | Hellenic Breast Surgeons SocietyOTHER | 1 | Jan 6, 2009 | clinicaltrials |
| NCT00548392 | Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement | completed | — | 25 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00108134 | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma | completed | Phase 2 | 60 | PeplinINDUSTRY | 1 | Dec 24, 2008 | clinicaltrials |
| NCT00131898 | A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma | completed | Phase 3 | 150 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 23, 2008 | clinicaltrials |
| NCT00290953 | Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide(SESAME) | completed | Phase 2 / Phase 3 | 432 | SanofiINDUSTRY | 14 | Dec 23, 2008 | clinicaltrials |
| NCT00812942 | Participation to Colorectal Cancer Screening With Fecal Occult Blood Test and Colonoscopy | completed | N/A | 9,889 | Istituto Superiore di SanitàOTHER | 1 | Dec 22, 2008 | clinicaltrials |
| NCT00444782 | A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma. | completed | Phase 2 | 41 | Pharmexa A/SINDUSTRY | 3 | Dec 18, 2008 | clinicaltrials |
| NCT00559429 | Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer(Tax-Sam) | completed | Phase 1 | 13 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 17, 2008 | clinicaltrials |
| NCT00157703 | G207 Followed by Radiation Therapy in Malignant Glioma | completed | Phase 1 | 9 | MediGeneINDUSTRY | 1 | Dec 16, 2008 | clinicaltrials |
| NCT00463073 | Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas | completed | Phase 2 | 32 | Rigshospitalet, DenmarkOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00806728 | Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease | completed | Phase 1 | 17 | MedImmune LLCINDUSTRY | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00306618 | Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma | completed | Phase 2 | 27 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Dec 10, 2008 | clinicaltrials |
| NCT00467792 | Natural History of Urticaria Pigmentosa in Children(UP) | completed | — | 47 | Medical College of WisconsinOTHER | 1 | Dec 8, 2008 | clinicaltrials |
| NCT00088088 | STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 86 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Dec 4, 2008 | clinicaltrials |
| NCT00088101 | STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors | completed | Phase 1 | 42 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Dec 4, 2008 | clinicaltrials |
Data updated 24 days agoSource updated Jan 29, 2009source: clinicaltrials